These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 17483482)

  • 1. HIV-1 escape from the entry-inhibiting effects of a cholesterol-binding compound via cleavage of gp41 by the viral protease.
    Waheed AA; Ablan SD; Roser JD; Sowder RC; Schaffner CP; Chertova E; Freed EO
    Proc Natl Acad Sci U S A; 2007 May; 104(20):8467-71. PubMed ID: 17483482
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mutations in the human immunodeficiency virus type 1 protease on cleavage of the gp41 cytoplasmic tail.
    Waheed AA; Ablan SD; Sowder RC; Roser JD; Schaffner CP; Chertova E; Freed EO
    J Virol; 2010 Mar; 84(6):3121-6. PubMed ID: 20042499
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of HIV-1 replication by amphotericin B methyl ester: selection for resistant variants.
    Waheed AA; Ablan SD; Mankowski MK; Cummins JE; Ptak RG; Schaffner CP; Freed EO
    J Biol Chem; 2006 Sep; 281(39):28699-711. PubMed ID: 16882663
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Domains of the human immunodeficiency virus type 1 matrix and gp41 cytoplasmic tail required for envelope incorporation into virions.
    Freed EO; Martin MA
    J Virol; 1996 Jan; 70(1):341-51. PubMed ID: 8523546
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of human immunodeficiency virus type 1 Env-mediated membrane fusion by viral protease activity.
    Murakami T; Ablan S; Freed EO; Tanaka Y
    J Virol; 2004 Jan; 78(2):1026-31. PubMed ID: 14694135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of envelope processing and gp41 membrane spanning domain in the formation of human immunodeficiency virus type 1 (HIV-1) fusion-competent envelope glycoprotein complex.
    Welman M; Lemay G; Cohen EA
    Virus Res; 2007 Mar; 124(1-2):103-12. PubMed ID: 17129629
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of human immunodeficiency virus type 1 envelope glycoprotein fusion by a membrane-interactive domain in the gp41 cytoplasmic tail.
    Wyss S; Dimitrov AS; Baribaud F; Edwards TG; Blumenthal R; Hoxie JA
    J Virol; 2005 Oct; 79(19):12231-41. PubMed ID: 16160149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oregano Oil and Its Principal Component, Carvacrol, Inhibit HIV-1 Fusion into Target Cells.
    Mediouni S; Jablonski JA; Tsuda S; Barsamian A; Kessing C; Richard A; Biswas A; Toledo F; Andrade VM; Even Y; Stevenson M; Tellinghuisen T; Choe H; Cameron M; Bannister TD; Valente ST
    J Virol; 2020 Jul; 94(15):. PubMed ID: 32461309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Susceptibility to virus-cell fusion at the plasma membrane is reduced through expression of HIV gp41 cytoplasmic domains.
    Malinowsky K; Luksza J; Dittmar MT
    Virology; 2008 Jun; 376(1):69-78. PubMed ID: 18400243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A mutation in the human immunodeficiency virus type 1 Gag protein destabilizes the interaction of the envelope protein subunits gp120 and gp41.
    Davis MR; Jiang J; Zhou J; Freed EO; Aiken C
    J Virol; 2006 Mar; 80(5):2405-17. PubMed ID: 16474147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HIV-1 protease, Gag and gp41 baseline substitutions associated with virological response to a PI-based regimen.
    Perrier M; Castain L; Regad L; Todesco E; Landman R; Visseaux B; Yazdanpanah Y; Rodriguez C; Joly V; Calvez V; Marcelin AG; Descamps D; Charpentier C
    J Antimicrob Chemother; 2019 Jun; 74(6):1679-1692. PubMed ID: 30768160
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Maturation-dependent human immunodeficiency virus type 1 particle fusion requires a carboxyl-terminal region of the gp41 cytoplasmic tail.
    Jiang J; Aiken C
    J Virol; 2007 Sep; 81(18):9999-10008. PubMed ID: 17609279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of natural polymorphism within the gp41 cytoplasmic tail of human immunodeficiency virus type 1 on the intracellular distribution of envelope glycoproteins and viral assembly.
    Lambelé M; Labrosse B; Roch E; Moreau A; Verrier B; Barin F; Roingeard P; Mammano F; Brand D
    J Virol; 2007 Jan; 81(1):125-40. PubMed ID: 17050592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail.
    Wyma DJ; Jiang J; Shi J; Zhou J; Lineberger JE; Miller MD; Aiken C
    J Virol; 2004 Apr; 78(7):3429-35. PubMed ID: 15016865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIV-1 Cell-Free and Cell-to-Cell Infections Are Differentially Regulated by Distinct Determinants in the Env gp41 Cytoplasmic Tail.
    Durham ND; Chen BK
    J Virol; 2015 Sep; 89(18):9324-37. PubMed ID: 26136566
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.
    Chen SS; Lee SF; Wang CT
    J Virol; 2001 Oct; 75(20):9925-38. PubMed ID: 11559825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutations at the C-terminus of the simian immunodeficiency virus envelope glycoprotein affect gp120-gp41 stability on virions.
    Affranchino JL; González SA
    Virology; 2006 Mar; 347(1):217-25. PubMed ID: 16380144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic evidence for an interaction between human immunodeficiency virus type 1 matrix and alpha-helix 2 of the gp41 cytoplasmic tail.
    Murakami T; Freed EO
    J Virol; 2000 Apr; 74(8):3548-54. PubMed ID: 10729129
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of human immunodeficiency virus type 1 assembly and release by the cholesterol-binding compound amphotericin B methyl ester: evidence for Vpu dependence.
    Waheed AA; Ablan SD; Soheilian F; Nagashima K; Ono A; Schaffner CP; Freed EO
    J Virol; 2008 Oct; 82(19):9776-81. PubMed ID: 18653459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of N-glycans of HIV-1 gp41 in virus infectivity and susceptibility to the suppressive effects of carbohydrate-binding agents.
    Mathys L; Balzarini J
    Retrovirology; 2014 Dec; 11():107. PubMed ID: 25499264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.